Literature DB >> 29028923

Detecting presence of mutational signatures in cancer with confidence.

Xiaoqing Huang1, Damian Wojtowicz1, Teresa M Przytycka1.   

Abstract

MOTIVATION: Cancers arise as the result of somatically acquired changes in the DNA of cancer cells. However, in addition to the mutations that confer a growth advantage, cancer genomes accumulate a large number of somatic mutations resulting from normal DNA damage and repair processes as well as carcinogenic exposures or cancer related aberrations of DNA maintenance machinery. These mutagenic processes often produce characteristic mutational patterns called mutational signatures. The decomposition of a cancer genome's mutation catalog into mutations consistent with such signatures can provide valuable information about cancer etiology. However, the results from different decomposition methods are not always consistent. Hence, one needs to be able to not only decompose a patient's mutational profile into signatures but also establish the accuracy of such decomposition.
RESULTS: We proposed two complementary ways of measuring confidence and stability of decomposition results and applied them to analyze mutational signatures in breast cancer genomes. We identified both very stable and highly unstable signatures, as well as signatures that previously have not been associated with breast cancer. We also provided additional support for the novel signatures. Our results emphasize the importance of assessing the confidence and stability of inferred signature contributions.
AVAILABILITY AND IMPLEMENTATION: All tools developed in this paper have been implemented in an R package, called SignatureEstimation, which is available from https://www.ncbi.nlm.nih.gov/CBBresearch/Przytycka/index.cgi\#signatureestimation. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Published by Oxford University Press 2017.

Entities:  

Year:  2018        PMID: 29028923      PMCID: PMC5860213          DOI: 10.1093/bioinformatics/btx604

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  17 in total

1.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

2.  Exploring background mutational processes to decipher cancer genetic heterogeneity.

Authors:  Alexander Goncearenco; Stephanie L Rager; Minghui Li; Qing-Xiang Sang; Igor B Rogozin; Anna R Panchenko
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

3.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

4.  APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.

Authors:  Stephen Henderson; Ankur Chakravarthy; Xiaoping Su; Chris Boshoff; Tim Robert Fenton
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

5.  Mutational signatures associated with tobacco smoking in human cancer.

Authors:  Ludmil B Alexandrov; Young Seok Ju; Kerstin Haase; Peter Van Loo; Iñigo Martincorena; Serena Nik-Zainal; Yasushi Totoki; Akihiro Fujimoto; Hidewaki Nakagawa; Tatsuhiro Shibata; Peter J Campbell; Paolo Vineis; David H Phillips; Michael R Stratton
Journal:  Science       Date:  2016-11-04       Impact factor: 47.728

6.  EMu: probabilistic inference of mutational processes and their localization in the cancer genome.

Authors:  Andrej Fischer; Christopher J R Illingworth; Peter J Campbell; Ville Mustonen
Journal:  Genome Biol       Date:  2013-04-29       Impact factor: 13.583

7.  DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.

Authors:  Nnennaya Kanu; Maria Antonietta Cerone; Gerald Goh; Lykourgos-Panagiotis Zalmas; Jirina Bartkova; Michelle Dietzen; Nicholas McGranahan; Rebecca Rogers; Emily K Law; Irina Gromova; Maik Kschischo; Michael I Walton; Olivia W Rossanese; Jiri Bartek; Reuben S Harris; Subramanian Venkatesan; Charles Swanton
Journal:  Genome Biol       Date:  2016-09-15       Impact factor: 13.583

Review 8.  Mutational signatures: the patterns of somatic mutations hidden in cancer genomes.

Authors:  Ludmil B Alexandrov; Michael R Stratton
Journal:  Curr Opin Genet Dev       Date:  2013-12-29       Impact factor: 5.578

9.  The topography of mutational processes in breast cancer genomes.

Authors:  Sandro Morganella; Ludmil B Alexandrov; Dominik Glodzik; Xueqing Zou; Helen Davies; Johan Staaf; Anieta M Sieuwerts; Arie B Brinkman; Sancha Martin; Manasa Ramakrishna; Adam Butler; Hyung-Yong Kim; Åke Borg; Christos Sotiriou; P Andrew Futreal; Peter J Campbell; Paul N Span; Steven Van Laere; Sunil R Lakhani; Jorunn E Eyfjord; Alastair M Thompson; Hendrik G Stunnenberg; Marc J van de Vijver; John W M Martens; Anne-Lise Børresen-Dale; Andrea L Richardson; Gu Kong; Gilles Thomas; Julian Sale; Cristina Rada; Michael R Stratton; Ewan Birney; Serena Nik-Zainal
Journal:  Nat Commun       Date:  2016-05-02       Impact factor: 14.919

10.  Landscape of somatic mutations in 560 breast cancer whole-genome sequences.

Authors:  Serena Nik-Zainal; Helen Davies; Johan Staaf; Manasa Ramakrishna; Dominik Glodzik; Xueqing Zou; Inigo Martincorena; Ludmil B Alexandrov; Sancha Martin; David C Wedge; Peter Van Loo; Young Seok Ju; Marcel Smid; Arie B Brinkman; Sandro Morganella; Miriam R Aure; Ole Christian Lingjærde; Anita Langerød; Markus Ringnér; Sung-Min Ahn; Sandrine Boyault; Jane E Brock; Annegien Broeks; Adam Butler; Christine Desmedt; Luc Dirix; Serge Dronov; Aquila Fatima; John A Foekens; Moritz Gerstung; Gerrit K J Hooijer; Se Jin Jang; David R Jones; Hyung-Yong Kim; Tari A King; Savitri Krishnamurthy; Hee Jin Lee; Jeong-Yeon Lee; Yilong Li; Stuart McLaren; Andrew Menzies; Ville Mustonen; Sarah O'Meara; Iris Pauporté; Xavier Pivot; Colin A Purdie; Keiran Raine; Kamna Ramakrishnan; F Germán Rodríguez-González; Gilles Romieu; Anieta M Sieuwerts; Peter T Simpson; Rebecca Shepherd; Lucy Stebbings; Olafur A Stefansson; Jon Teague; Stefania Tommasi; Isabelle Treilleux; Gert G Van den Eynden; Peter Vermeulen; Anne Vincent-Salomon; Lucy Yates; Carlos Caldas; Laura van't Veer; Andrew Tutt; Stian Knappskog; Benita Kiat Tee Tan; Jos Jonkers; Åke Borg; Naoto T Ueno; Christos Sotiriou; Alain Viari; P Andrew Futreal; Peter J Campbell; Paul N Span; Steven Van Laere; Sunil R Lakhani; Jorunn E Eyfjord; Alastair M Thompson; Ewan Birney; Hendrik G Stunnenberg; Marc J van de Vijver; John W M Martens; Anne-Lise Børresen-Dale; Andrea L Richardson; Gu Kong; Gilles Thomas; Michael R Stratton
Journal:  Nature       Date:  2016-05-02       Impact factor: 49.962

View more
  28 in total

Review 1.  Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance.

Authors:  Hanane Omichessan; Gianluca Severi; Vittorio Perduca
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

2.  Modeling clinical and molecular covariates of mutational process activity in cancer.

Authors:  Welles Robinson; Roded Sharan; Mark D M Leiserson
Journal:  Bioinformatics       Date:  2019-07-15       Impact factor: 6.937

3.  MetaMutationalSigs: Comparison of mutational signature refitting results made easy.

Authors:  Palash Pandey; Sanjeevani Arora; Gail L Rosen
Journal:  Bioinformatics       Date:  2022-02-14       Impact factor: 6.937

4.  ScalpelSig Designs Targeted Genomic Panels from Data to Detect Activity of Mutational Signatures.

Authors:  Nicholas Franzese; Jason Fan; Roded Sharan; Mark D M Leiserson
Journal:  J Comput Biol       Date:  2022-01-05       Impact factor: 1.479

5.  Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.

Authors:  Peter Georgeson; Bernard J Pope; Christophe Rosty; Mark Clendenning; Khalid Mahmood; Jihoon E Joo; Romy Walker; Ryan A Hutchinson; Susan Preston; Julia Como; Sharelle Joseland; Aung Ko Win; Finlay A Macrae; John L Hopper; Dmitri Mouradov; Peter Gibbs; Oliver M Sieber; Dylan E O'Sullivan; Darren R Brenner; Steve Gallinger; Mark A Jenkins; Ingrid M Winship; Daniel D Buchanan
Journal:  Gut       Date:  2021-01-07       Impact factor: 23.059

6.  Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.

Authors:  Shixiang Wang; Huimin Li; Minfang Song; Ziyu Tao; Tao Wu; Zaoke He; Xiangyu Zhao; Kai Wu; Xue-Song Liu
Journal:  PLoS Genet       Date:  2021-05-04       Impact factor: 5.917

7.  Mutational signatures associated with exposure to carcinogenic microplastic compounds bisphenol A and styrene oxide.

Authors:  Xiaoju Hu; Antara Biswas; Anchal Sharma; Halle Sarkodie; Ivy Tran; Indrani Pal; Subhajyoti De
Journal:  NAR Cancer       Date:  2021-03-01

8.  Targeted Deep Sequencing of Bladder Tumors Reveals Novel Associations between Cancer Gene Mutations and Mutational Signatures with Major Risk Factors.

Authors:  Debra T Silverman; Nathaniel Rothman; Michael Dean; Stella Koutros; Nina Rao; Lee E Moore; Michael L Nickerson; Donghyuk Lee; Bin Zhu; Larissa A Pardo; Dalsu Baris; Molly Schwenn; Alison Johnson; Kristine Jones; Montserrat Garcia-Closas; Ludmila Prokunina-Olsson
Journal:  Clin Cancer Res       Date:  2021-04-13       Impact factor: 13.801

Review 9.  Mutational signatures: emerging concepts, caveats and clinical applications.

Authors:  Gene Koh; Andrea Degasperi; Xueqing Zou; Sophie Momen; Serena Nik-Zainal
Journal:  Nat Rev Cancer       Date:  2021-07-27       Impact factor: 60.716

10.  Sigflow: an automated and comprehensive pipeline for cancer genome mutational signature analysis.

Authors:  Shixiang Wang; Ziyu Tao; Tao Wu; Xue-Song Liu
Journal:  Bioinformatics       Date:  2021-07-12       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.